期刊文献+

UGT1A1 罕见突变的发现及与对血清胆红素水平变化的相关性分析

Rear Mutation in UGT1A1 and its Effect on Serum Bilirubin Level
原文传递
导出
摘要 目的:在中国汉族人群中查找其他UGT1A1基因突变类型并探究其对血清胆红素水平变化的相关性分析。方法:收集471名中国汉族人群血液标本,采用聚合酶链式反应-单链核苷酸多态性(PCR-SSCP)进行UGT1A1-118 TATA盒的分型,挑选出突变基因型的携带者,并对其家系进行调查及分析。结果:471名受试者中分别发现UGT1A1-118(TA)6/6351名(74.5%),UGT1A1-118(TA)6/7107名(22.7%),UGT1A1-118(TA)7/711名(2.3%),UGT1A1-118(TA)5/72名(0.4%)。对2例罕见基因携带者复测发现血清胆红素水平略微升高,家系中仅出现1例该基因携带者,但其血清胆红素水平正常。结论:中国汉族人群中存在的3例UGT1A1*36/*37携带者,其突变基因与胆红素水平升高暂无明显相关。 Objective UGT1A1 is the key enzyme of bilirubin metabolism,its metabolite indirect bilirubin transfer to direct bilirubin and then eliminate.The most common polymorphism in Chinese is the one in promoter TATA box region(UGT1A1*28)and one in exon 1(UGT1A1*6 Q331X).The purpose of this study is to find out the mutation types of UGT1A1 gene and the correlation analysis of serum bilirubin level in Chinese Han population.Methods The blood samples of 471 Chinese Han people were collected,and the ugt1a1-118 TATA box was typed by PCR-SSCP.The carriers of the mutant genotype were selected,and their families were investigated and analyzed.Results 74.5(351person)patients carry UGT1A1-118(TA)6/6.22.7%(107person)patients carry UGT1A1-118(TA)6/7.2.3%(11person)carry UGT1A1-118(TA)7/7.0.4%(2person)carry UGT1A1-118(TA)5/7.The level of serum bilirubin was slightly increased in 2 cases of rare gene carriers by retest.Only 1 case of the gene carrier was found in the family But its serum bilirubin level is normal.Conclusion There are 3 cases of UGT1A1*36/*37 carriers in Chinese Han population,and there is no significant correlation between the mutation gene and bilirubin level.
作者 邵雅琴 王炜 Shao Ya-qin;Wang Wei(Hunan University of Chinese Medicine,Changsha 410208,China)
机构地区 湖南中医药大学
出处 《湖南师范大学学报(医学版)》 2020年第4期67-70,共4页 Journal of Hunan Normal University(Medical Sciences)
关键词 UGT1A1基因多态性 尿苷二磷酸葡萄糖醛酸基转移酶 UGT1A1*36/*37 UGT1A1 gene mutation UGT1A1 UGT1A1*36/*37
  • 相关文献

参考文献1

二级参考文献20

  • 1Raijmakers MT,Jansen PL,Steegers EA,et al.Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGTlAl gene.J Hepatol,2000,33:348-351.
  • 2Toffoli G,Cecchin E,Corona G,et al.The role of UGT1A1*28 polymorphism in the pharmacodynamics and pharmacokinetics of irinotecan in patients with metastatic colorectal cancer.J Clin Oncol,2006,24:3061-3068.
  • 3Innocenti F,Vokes EE,Ratain MJ,et al.Irinogenetics:what is the right star? J Clin Oncol,2006,24:2221-2224.
  • 4Cailliera B,Lé Pinea J,Tojcica J,et al.A pharmacogenomics study of the human estrogen glucuronosyltransferase UGT1A3.Pharmacogenet Genomics,2007,17:481-495.
  • 5Sun DX,Chen G,Dellinger RW,et al.Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants.Breast Cancer Res,2006,8:R50.
  • 6Mori A,Maruo Y,Iwai M,et al.UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of Clozapine.Drug Metab Dispos,2005,33:672-675.
  • 7Finel M,Li X,Gardner-Stephen D,et al.Human UDP-glucuronosyltransferase 1A5:identification,expression and activity.J Pharmacol Exp Ther,2005,315:1143-1149.
  • 8Krishnaswamy S,Hao Q,Al-Rohaimi A.UDP-glucuronosyltransferase (UGT) 1A6 pharmacogenetics:II.Functional impact of the three most common nonsynonymous UGT1A6 polymorphisms (S7A,T181A,and R184S).J Pharmacol Exp Ther,2005,313:1340-1346.
  • 9Tankanitlert J,Morales NP,Howard TA,et al.Effects of combined UDP-glucuronosyltransferase (UGT)1A1*28 and UGT1A6*2 on paracetamol pharmacokinetics in β-thalassemia/HbE.Pharmacology,2007,79:97-103.
  • 10Wang Y,Kato N,Hoshida Y,et al.UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in japanese patients with hepatitis c virus infection.Clin Cancer Res,2004,10:2441-2446.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部